[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349888-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349888-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","precision-pediatric-cancer-nanomedicine-advancing-personalized-nano-therapies-to-reduce-non-communicable-diseases-through-ai-driven-3d-printed-drugs","Precision Pediatric Cancer Nanomedicine - Advancing Personalized Nano Therapies to Reduce Non-Communicable Diseases Through AI-Driven 3D-Printed Drugs","","Pediatric cancers require treatments that preserve cure rates while minimizing long-term toxicity and noncommunicable diseases, yet conventional dosing and adult-oriented formulations create major childhood cancer-care limitations. This review synthesizes evidence from AI and 3D nanoprinting to enable personalized pediatric oncology. A structured search (PubMed, Scopus, Web of Science, Google Scholar, 2005–2024) organizes findings by cancer type, clinical use, and effects on toxicity, adherence, and survivorship. AI-supported tools improve individualized chemotherapy exposure, anticipate toxicity using clinical or pharmacogenomic markers, and support early regimen modifications. Meanwhile, 3D nano printing enables child-friendly medicines, multi-drug polypills, and controlled-release formulations to reduce dosing errors and enhance adherence. Early experience with Bayesian therapeutic drug monitoring and on-demand pediatric printing indicates high clinical feasibility, with recommendations for multicenter studies and broader hospital printing capacity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/precision-pediatric-cancer-nanomedicine-advancing-personalized-nano-therapies-to-reduce-non-communicable-diseases-through-ai-driven-3d-printed-drugs/349888/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/precision-pediatric-cancer-nanomedicine-advancing-personalized-nano-therapies-to-reduce-non-communicable-diseases-through-ai-driven-3d-printed-drugs/349888.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why does pediatric cancer treatment require more personalized approaches?","Question",{"text":63,"@type":64},"Most medicines are designed for adults and adapted for children, which can cause dosing errors, poor adherence, and harmful side effects. Long-term survivors may also face noncommunicable disease risks such as cardiotoxicity, hearing loss, and learning difficulties.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do AI-driven tools contribute to pediatric oncology in the review?",{"text":68,"@type":64},"AI-supported platforms can improve individualized chemotherapy exposure and anticipate toxicity using clinical or pharmacogenomic markers. They also help clinicians modify early treatment to better match the child’s needs.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does 3D nano printing play in improving pediatric medications?",{"text":72,"@type":64},"3D nano printing supports child-friendly medicines, multi-drug polypills, and controlled-release formulations. These approaches aim to reduce dosing errors and improve adherence by tailoring to age, weight, and treatment plan.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349888,1790300876,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","International Journal of Nanomedicine  \nOpen Access Full Text Article REVIEW  \nPrecision Pediatric Cancer Nanomedicine: Advancing Personalized Nano Therapies to Reduce Non-Communicable Diseases Through AI-Driven 3D-Printed Drugs  \nNeeraj Choudhary 1 , Dinesh Kumar 1 , Thakur Prava Jyoti 2 , Bhupendra G Prajapati 3 , Mohamed Kchaou4 , Thomas J Webster 5–7 , Md Faiyazuddin 8  \n1GNA School of Pharmacy, GNA University, Phagwara, Punjab, 144401, India; 2University College of Pharmaceutical Sciences, Guru Kashi University, Talwandi Sabo, Bathinda, Punjab, 151302, India; 3Department of Pharmaceutics, Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, 391760, India; 4Department of Industrial Engineering, College of Engineering, University of Bisha, Bisha, Saudi Arabia; 5Division of Pre-College and Undergraduate Studies, Brown University, Providence, RI, 02917, USA; 6School of Health Sciences and Biomedical Engineering, Hebei University of Technology, Tianjin, 300131, People’s Republic of China; 7School of Engineering, Saveetha University, Chennai, 600077, India; 8Center for Global Health Research, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India  \nCorrespondence: Md Faiyazuddin; Thomas J Webster, [Email md.faiyazuddin@gmail.com](Email md.faiyazuddin@gmail.com); [thomas_webster@brown.edu](thomas_webster@brown.edu)  \n\n| Abstract: Pediatric cancers (PC) require treatments that maintain cure rates while minimizing long-term toxicity and noncommunicable diseases. Yet, conventional dosing, adult-oriented formulations, and high treatment burden remain major limitations in childhood cancer care. This review synthesizes the current evidence using artificial intelligence (AI) and 3D nano printing as emerging tools to support personalized pediatric oncology. A structured literature search of PubMed, Scopus, Web of Science, and Google Scholar (2005–2024) identified English-language studies related to pediatric cancer, nanomedicine (NM), 3D printing, precision dosing, and pharmacogenomics, and relevant findings were organized by cancer type, clinical application, and potential impact on toxicity, adherence, and survivorship. Across leukemia, neuroblastoma, brain tumors, bone sarcoma, and lymphoma, AIsupported platforms were found to improve individualized chemotherapy exposure, anticipate toxicity based on clinical or pharmacogenomic markers, and assist clinicians towards modifying early treatment. At the same time, 3D nano printing enabled child-friendly medicines, multi-drug polypills, and controlled-release formulations that reduced dosing errors and improved treatment adherence. Early hospital-based experience with Bayesian therapeutic drug monitoring and on-demand pediatric drug printing suggested high feasibility for real clinical settings. Overall, AI-guided dosing and nano-printed formulations enhanced precision, lowering acute and late toxicities that support healthier long-term outcomes in children with cancer, particularly when linked to disease-specific needs. Further multicenter pediatric studies, regulatory development, and expansion of hospital 3D printing capacity are recommended to enable safe and equitable translation of these technologies into routine clinical care.\u003Cbr>Keywords: pediatric oncology, artificial intelligence, 3D printing, personalized medicine, non-communicable diseases |\n| --- |\n| Introduction\u003Cbr>Every year, more than 400,000 children are diagnosed with cancer, making it one of the leading causes of childhood illness and death worldwide.1 While survival rates for acute lymphoblastic leukemia are above 90% in high-income countries, they remain below 40% in many low and middle-income countries. Even for children who survive, current treatments often bring serious challenges. Most medicines are designed for adults and then adapted for children, which can lead to dosing errors, poor adherence, and harmful side effects. Long-term survivors al","cbCaiuMJS6DVsjo4","https://ap.wps.com/l/cbCaiuMJS6DVsjo4","pdf",14086173,32,"English","# Introduction\n## Background: pediatric cancer burden and limitations of current therapies\n## Need for safer, personalized pediatric treatment","[{\"question\":\"Why does pediatric cancer treatment require more personalized approaches?\",\"answer\":\"Most medicines are designed for adults and adapted for children, which can cause dosing errors, poor adherence, and harmful side effects. Long-term survivors may also face noncommunicable disease risks such as cardiotoxicity, hearing loss, and learning difficulties.\"},{\"question\":\"How do AI-driven tools contribute to pediatric oncology in the review?\",\"answer\":\"AI-supported platforms can improve individualized chemotherapy exposure and anticipate toxicity using clinical or pharmacogenomic markers. They also help clinicians modify early treatment to better match the child’s needs.\"},{\"question\":\"What role does 3D nano printing play in improving pediatric medications?\",\"answer\":\"3D nano printing supports child-friendly medicines, multi-drug polypills, and controlled-release formulations. These approaches aim to reduce dosing errors and improve adherence by tailoring to age, weight, and treatment plan.\"}]","Precision Pediatric Cancer Nanomedicine - Advancing Personalized Nano Therapies to Reduce Non-Communicable Diseases Through AI-Driven 3D-Printed Drugs | PDF",1790086083,81,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/004166b8127d9954233346af95dac79a.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98002fb35be5e0e8fb8b507f11584bda.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/027c337f2a07d15345c89565f02d78f2.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5394bbd295ca46afc1b3d4532e6cca16.webp",980,1268]